Urinary Fractional Excretion of Phosphorus in Dogs with Spontaneous Chronic Kidney Disease

Abstract

Abstract:The increase of urinary fractional excretion of phosphorus (uFEP) may indicate phosphorus retention before the onset of hyperphosphatemia in the early stages of chronic kidney disease (CKD). The hypothesis of this study is whether uFEP may increase during the early stage of CKD as a compensatory mechanism to prevent hyperphosphatemia as well as whether hyperphosphatemia in the late stages is associated with increase or decrease in uFEP in dogs with naturally occurring CKD; therefore, the aim of this study was to determine the uFEP in CKD dogs with different stages. Forty-nine CKD dogs were included, and they were divided into stage 1 (serum creatinine < 1.4 mg/dL), stage 2 (serum creatinine 1.5 to 2.0 mg/dL), stage 3 (serum creatinine 2.1 to 5.0 mg/dL) and stage 4 (serum creatinine > 5.0 mg/dL), according to the IRIS staging criteria. The stage 3 was subdivided into stage 3-A (serum creatinine 2.1 to 3.5 mg/dL) and stage 3-B (serum creatinine 3.6 to 5.0 mg/dL). The control group comprised 10 dogs, and uFEP ≤ 40% was considered as normal. A progressive increase in uFEP along the progression of CKD was found. However, similar results of uFEP levels were observed in late CKD, since there were no differences between stages 3 (A, B) and 4. Interestingly, some CKD dogs with stage 4 showed normal or reduced uFEP, besides hyperphosphatemia; conversely, some dogs in early CKD had increased uFEP values and normophosphatemia. Our findings suggest that uFEP may act as a compensatory mechanism to avoid the onset of hyperphosphatemia in early CKD, but not in later stages. uFEP assessment may be considered as an additional tool for the diagnostic and monitoring of phosphate disorders in dogs with CKD, since it may help to identify disturbances of phosphorus balance. More studies are needed to elucidate the role of uFEP in phosphorus homeostasis in dogs with CKD.

Fibroblast growth factor‐23 as an early marker of CKD‐mineral bone disorder in dogs: preliminary investigation

“…However, uFEP was not identified as an independent predictor of FGF-23 in our multivariable analysis. A previous study has shown that uFEP was similar between CKD dogs with IRIS stage 3 and 4 (Martorelli et al 2017). In our study, while there was no significant difference between dogs with IRIS stages 2-4 for uFEP, FGF-23 progressively increased in dogs with CKD, even at the later stage.…”

Mathematical Modelling Using Predictive Biomarkers for the Outcome of Canine Leishmaniasis upon Chemotherapy

“…In chronic renal disease, which is common in CanL, anemia also results from decreased erythropoietin production in the kidney [8,48]. Kidneys are the main route for phosphorus excretion and hyperphosphatemia promotes progressive renal lesions [49], as described in dogs with late-stage CanL [50]. Serum globulin and acute phase proteins levels, proteinuria and UPC ratio are considered biomarkers for the clinical monitoring of dogs during leishmanicidal treatment and post-treatment [3,17,18,51,52].…”

Feline Morbillivirus Infection in Domestic Cats: What Have We Learned So Far?

“…In addition, urinary qualitative proteinuria and electrolytes urinary fractional excretion have been considered in the assessment of renal damage [ 7 , 50 ]. Specifically, qualitative proteinuria and proteomics allow the analysis of biomarkers indicative of kidney damage such as cauxin, uromodulin, and retinol binding protein [ 50 , 51 , 52 ].…”